Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

A newly released ACC Expert Consensus Decision Pathway (ECDP) focused on the clinical assessment, management and trajectory of patients hospitalized with heart failure (HF) includes revisions to the ...

View a comprehensive list of frequently asked questions regarding ACC’s committee appointment process and application portal.

The SGLT2 inhibitor empagliflozin did not lower the risk of a first hospitalization for heart failure (HF) or death from any cause among patients with an increased risk for HF following acute ...

The ACC has issued guidance for the diagnosis and management of acute myocarditis in adult patients, delivering a streamlined decision-making framework that reflects recent advancements in clinical ...

The U.S. Food and Drug Administration (FDA) announced on April 15 that Abbott/Thoratec Corp. is recalling the Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) due to long-term ...

Lipoprotein (a) (Lp [a]) is a low-density lipoprotein–like molecule with an apolipoprotein (b) moiety that is covalently attached to apolipoprotein (a) (Apo [a]), a plasminogen-like protein that ...

Chest pain is one of the most common reasons that people seek medical care. This guideline was developed for the evaluation of acute or stable chest pain in outpatient and emergency department ...

New Study Finds Chronic High Caffeine Consumption May Heighten Risk for Cardiovascular Disease The findings will be presented at ACC Asia 2024 ...

Introduction and Scope of the Problem The incidence of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep venous thromboembolism (DVT), in the United States is unclear because ...

More Than Skin Color: Ethnicity-Specific BMI Cutoffs For Obesity Based on Type 2 Diabetes Risk in England ...

Contact: Olivia Walther, [email protected], WASHINGTON (Dec 11, 2023) - A world without cardiovascular disease (CVD) is possible, yet millions of lives are lost prematurely to heart disease each year, ...